BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8256855)

  • 21. Histology of melanoma and nonmelanoma skin cancer.
    Mueller CS; Reichrath J
    Adv Exp Med Biol; 2008; 624():215-26. PubMed ID: 18348459
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased elafin expression in cystic, dysplastic and neoplastic oral tissues.
    Robinson PA; Markham AF; Schalkwijk J; High AS
    J Oral Pathol Med; 1996 Mar; 25(3):135-9. PubMed ID: 8860145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. βKlotho expression is reduced in human non-melanoma skin cancer.
    Nakai K; Yoneda K; Haba R; Kushida Y; Katsuki N; Moriue J; Moriue T; Koura A; Yokoi I; Ishikawa E; Inoue S; Kubota Y
    Int J Dermatol; 2015 Oct; 54(10):e431-3. PubMed ID: 26234379
    [No Abstract]   [Full Text] [Related]  

  • 24. Skin tumors.
    Traub EF
    Cutis; 1976 Sep; 18(3):366-72. PubMed ID: 189972
    [No Abstract]   [Full Text] [Related]  

  • 25. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.
    Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J
    J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tricholemmoma and clear cell squamous cell carcinoma (associated with Bowen's disease): immunohistochemical profile in comparison to normal hair follicles.
    Misago N; Toda S; Narisawa Y
    Am J Dermatopathol; 2012 Jun; 34(4):394-9. PubMed ID: 22452951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha with progression of keratinocytic neoplasms.
    Lining X; Uchi H; Hayashida S; Tsuji G; Kido M; Nakahara T; Takeuchi S; Takahara M; Moroi Y; Furue M
    J Dermatol Sci; 2009 Nov; 56(2):135-6. PubMed ID: 19660915
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidermoid carcinomas].
    Ortonne N
    Ann Dermatol Venereol; 2003; 130(6-7):667-9. PubMed ID: 13679711
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
    Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
    J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal cell and squamous cell carcinomas. Clinico-histological features.
    Annessi G; Baliva G
    Ann Ist Super Sanita; 1996; 32(1):29-36. PubMed ID: 8804183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNF-alpha and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway.
    Pfundt R; Wingens M; Bergers M; Zweers M; Frenken M; Schalkwijk J
    Arch Dermatol Res; 2000 Apr; 292(4):180-7. PubMed ID: 10836611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and application of monoclonal antibodies against SKALP/elafin and other trappin family members.
    Vandermeeren M; Daneels G; Bergers M; van Vlijmen-Willems I; Pol A; Geysen J; Schalkwijk J
    Arch Dermatol Res; 2001 Jul; 293(7):343-9. PubMed ID: 11550807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients.
    Alkemade H; van de Kerkhof P; Schalkwijk J
    J Invest Dermatol; 1992 Jul; 99(1):3-7. PubMed ID: 1607676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
    Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. bcl-2 expression in epidermal keratinocytic diseases.
    Nakagawa K; Yamamura K; Maeda S; Ichihashi M
    Cancer; 1994 Sep; 74(6):1720-4. PubMed ID: 8082073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The basal lamina in basal cell carcinoma, Bowen's disease, squamous cell carcinoma and keratoacanthoma: an immunoperoxidase study using an antibody to type IV collagen.
    McArdle JP; Roff BT; Muller HK; Murphy WH
    Pathology; 1984 Jan; 16(1):67-72. PubMed ID: 6371685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical localization of a novel beta 1 integrin in normal and pathologic squamous epithelia.
    Cerri A; Favre A; Giunta M; Corte G; Grossi CE; Berti E
    J Invest Dermatol; 1994 Feb; 102(2):247-52. PubMed ID: 7508965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered distribution of 1-2B7B antigen in basal cell carcinoma, squamous cell carcinoma and Bowen's disease.
    Zhang XM; Horiguchi Y; Ueda M; Yoshiki T; Imamura S
    J Dermatol Sci; 1992 Jan; 3(1):46-55. PubMed ID: 1591227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.